{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:16:43Z","timestamp":1791001003218,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Science and Technology Plan of Jiangxi Provincial Health and Family Planning","award":["20141282"],"award-info":[{"award-number":["20141282"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.yexcr.2019.01.019","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T11:00:44Z","timestamp":1548846044000},"page":"11-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["CSN5 attenuates Ang II-induced cardiac hypertrophy through stabilizing LKB1"],"prefix":"10.1016","volume":"376","author":[{"given":"Zhiyong","family":"Sheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tieqiu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2019.01.019_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yexcr.2019.01.019_bib2","first-page":"3037","article-title":"Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response","volume":"5","author":"Chien","year":"1991","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.yexcr.2019.01.019_bib3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0092-8674(93)90541-W","article-title":"Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro","volume":"75","author":"Sadoshima","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2019.01.019_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.RES.73.3.413","article-title":"Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype","volume":"73","author":"Sadoshima","year":"1993","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexcr.2019.01.019_bib5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/383453a0","article-title":"A new group of conserved coactivators that increase the specificity of AP-1 transcription factors","volume":"383","author":"Claret","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2019.01.019_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1747-1028-5-26","article-title":"JAB1\/CSN5: a new player in cell cycle control and cancer","volume":"5","author":"Shackleford","year":"2010","journal-title":"Cell Div."},{"key":"10.1016\/j.yexcr.2019.01.019_bib7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4161\/cbt.27823","article-title":"Emerging roles of Jab1\/CSN5 in DNA damage response, DNA repair, and cancer","volume":"15","author":"Pan","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.yexcr.2019.01.019_bib8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0092-8674(03)00722-0","article-title":"COP9 signalosome: a multifunctional regulator of SCF and other cullin-based ubiquitin ligases","volume":"114","author":"Cope","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2019.01.019_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.gene.2018.11.061","article-title":"The pivotal oncogenic role of Jab1\/CSN5 and its therapeutic implications in human cancer","volume":"687","author":"Guo","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.yexcr.2019.01.019_bib10","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.yjmcc.2006.01.007","article-title":"CSN5\/Jab1 inhibits cardiac L-type Ca2+ channel activity through protein-protein interactions","volume":"40","author":"Kameda","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yexcr.2019.01.019_bib11","doi-asserted-by":"crossref","first-page":"E2766","DOI":"10.1073\/pnas.1618411114","article-title":"Inhibition of atherogenesis by the COP9 signalosome subunit 5 in vivo","volume":"114","author":"Asare","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yexcr.2019.01.019_bib12","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.bbrc.2016.09.147","article-title":"The oxoglutarate receptor 1 (OXGR1) modulates pressure overload-induced cardiac hypertrophy in mice","volume":"479","author":"Omede","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2019.01.019_bib13","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Mihaylova","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.yexcr.2019.01.019_bib14","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.3892\/or.2015.4288","article-title":"Role of the LKB1\/AMPK pathway in tumor invasion and metastasis of cancer cells (Review)","volume":"34","author":"Li","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.yexcr.2019.01.019_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-319-18440-1_11","article-title":"Modulation of the LKB1-AMPK signalling pathway underpins hypoxic pulmonary vasoconstriction and pulmonary hypertension","volume":"860","author":"Evans","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.yexcr.2019.01.019_bib16","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.CIR.0000121426.43044.2B","article-title":"Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy","volume":"109","author":"Tsybouleva","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2019.01.019_bib17","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.1038\/srep07425","article-title":"Functional role of Calstabin2 in age-related cardiac alterations","volume":"4","author":"Yuan","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2019.01.019_bib18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCRESAHA.116.304707","article-title":"MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1\/AMPK pathway","volume":"116","author":"Kuwabara","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexcr.2019.01.019_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.abb.2014.06.023","article-title":"AMPK inhibits cardiac hypertrophy by promoting autophagy via mTORC1","volume":"558","author":"Li","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.yexcr.2019.01.019_bib20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc2676","article-title":"The LKB1-AMPK pathway: metabolism and growth control in tumour suppression","volume":"9","author":"Shackelford","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2019.01.019_bib21","first-page":"408","article-title":"Sestrin2 promotes LKB1-mediated AMPK activation in the ischemic heart","volume":"29","author":"Morrison","year":"2015","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.yexcr.2019.01.019_bib22","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ccell.2016.10.010","article-title":"Deubiquitination and stabilization of PD-L1 by CSN5","volume":"30","author":"Lim","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexcr.2019.01.019_bib23","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.molcel.2015.01.015","article-title":"Skp2-dependent ubiquitination and activation of LKB1 is essential for cancer cell survival under energy stress","volume":"57","author":"Lee","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.yexcr.2019.01.019_bib24","unstructured":"M. Gedela, M. Khan, O. Jonsson, Heart Failure, South Dakota medicine : the journal of the South Dakota State Medical Association 68 (2015) 403-405, 407-409."},{"key":"10.1016\/j.yexcr.2019.01.019_bib25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.yjmcc.2016.01.001","article-title":"AMPK in cardiac fibrosis and repair: actions beyond metabolic regulation","volume":"91","author":"Daskalopoulos","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yexcr.2019.01.019_bib26","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.117.028728","article-title":"SIRT2 acts as a cardioprotective deacetylase in pathological cardiac hypertrophy","volume":"136","author":"Tang","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2019.01.019_bib27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.metabol.2015.10.022","article-title":"The protective effect of trimetazidine on myocardial ischemia\/reperfusion injury through activating AMPK and ERK signaling pathway","volume":"65","author":"Liu","year":"2016","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.yexcr.2019.01.019_bib28","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/ajh\/hpu017","article-title":"Retinoid X receptor agonists inhibit hypertension-induced myocardial hypertrophy by modulating LKB1\/AMPK\/p70S6K signaling pathway","volume":"27","author":"Zhu","year":"2014","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.yexcr.2019.01.019_bib29","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41467-017-02795-4","article-title":"AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation","volume":"9","author":"Gelinas","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2019.01.019_bib30","doi-asserted-by":"crossref","first-page":"35839","DOI":"10.1074\/jbc.M109.057273","article-title":"Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction","volume":"284","author":"Ikeda","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2019.01.019_bib31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.freeradbiomed.2018.05.004","article-title":"C1QTNF1 attenuates angiotensin II-induced cardiac hypertrophy via activation of the AMPKa pathway","volume":"121","author":"Wu","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.yexcr.2019.01.019_bib32","series-title":"Exp. Cell Res.","article-title":"CSN5 promotes the invasion and metastasis of pancreatic cancer by stabilization of FOXM1","author":"Mao","year":"2018"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482718311467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482718311467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:15:56Z","timestamp":1762146956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482718311467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0014482718311467"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2019.01.019","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSN5 attenuates Ang II-induced cardiac hypertrophy through stabilizing LKB1","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2019.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}